Dr. Ning Xu is currently the Vice President, Head of Clinical Development Service, Covance China. Dr. Xu has many years of experience of clinical research both in pharmaceutical and CRO industries. He had worked for pharmaceutical companies such as J&J and GSK as well as CROs such as Excel PharmaStudies and Parexel US. Dr. Xu is the Chairman of DIA China and DIA global board of director.
Dr. Xu got his M.D. from Peking Union Medical Colleague in 1991. As a pulmonary physician he worked in Beijing Union Hospital for 6 years, and then he completed his postdoctoral fellowship in the Medical School, University of Illinois at Chicago, investigating on neutrophil inhibitory factor in preventing acute lung injury. He got his MBA from the University of Illinois at Chicago in 2000.